​
Login / Signup
Xiaojie Pan
ORCID
Publication Activity (10 Years)
Years Active: 2022-2023
Publications (10 Years): 6
Top Topics
Epithelial Mesenchymal Transition
Protein Protein
Current Status
Top Venues
BioMed research international
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Zhaoxian Lin
,
Jianyuan Huang
,
Lihuan Zhu
,
Xing Lin
,
Yangyun Huang
,
Chun Chen
,
Xiaojie Pan
TRIM9 Interacts with ZEB1 to Suppress Esophageal Cancer by Promoting ZEB1 Protein Degradation via the UPP Pathway.
BioMed research international
2023 (2023)
Zhaoxian Lin
,
Jianyuan Huang
,
Lihuan Zhu
,
Xing Lin
,
Yangyun Huang
,
Chun Chen
,
Xiaojie Pan
TRIM9 Interacts with ZEB1 to Suppress Esophageal Cancer by Promoting ZEB1 Protein Degradation via the UPP Pathway.
BioMed research international
2023 (2023)
Zhaoxian Lin
,
Jianyuan Huang
,
Lihuan Zhu
,
Xing Lin
,
Yangyun Huang
,
Chun Chen
,
Xiaojie Pan
TRIM9 Interacts with ZEB1 to Suppress Esophageal Cancer by Promoting ZEB1 Protein Degradation via the UPP Pathway.
BioMed research international
2023 (2023)
Lihuan Zhu
,
Zhizhong Chen
,
Tianxing Guo
,
Wenshu Chen
,
Li-Lan Zhao
,
Lingwen Guo
,
Xiaojie Pan
USP2 Inhibits Lung Cancer Pathogenesis by Reducing ARID2 Protein Degradation via Ubiquitination.
BioMed research international
2022 (2022)
Lihuan Zhu
,
Zhizhong Chen
,
Tianxing Guo
,
Wenshu Chen
,
Li-Lan Zhao
,
Lingwen Guo
,
Xiaojie Pan
USP2 Inhibits Lung Cancer Pathogenesis by Reducing ARID2 Protein Degradation via Ubiquitination.
BioMed research international
2022 (2022)
Lihuan Zhu
,
Zhizhong Chen
,
Tianxing Guo
,
Wenshu Chen
,
Li-Lan Zhao
,
Lingwen Guo
,
Xiaojie Pan
USP2 Inhibits Lung Cancer Pathogenesis by Reducing ARID2 Protein Degradation via Ubiquitination.
BioMed research international
2022 (2022)